To assess the feasibility of SG gene therapy for treatment of DM, we generated a recombinant adenoviral (rAd) serotype 5 vector that encodes the cDNA for wild type human proinsulin (hProinsulin-WT) under the direction of the cytomegalovirus (CMV) promoter. Here, INS is linked to diabetes mellitus.